Company Filing History:
Years Active: 2005
Title: The Innovative Contributions of Allison Gillespie
Introduction
Allison Gillespie is a notable inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the area of neuronal nicotinic acetylcholine receptors. Her work has implications for understanding various neurological functions and potential therapeutic applications.
Latest Patents
Allison Gillespie holds a patent for "DNA Encoding Human α and β Subunits of Neuronal Nicotinic Acetylcholine Receptor, Cells Transformed Therewith, and Recombinant Cell Line Expressing a Human α and β Subunit of Neuronal Nicotinic Acetylcholine Receptor." This patent includes isolated nucleic acid molecules, such as DNA or RNA, that encode the human neuronal nicotinic acetylcholine receptor alpha and beta subunits. It also describes methods for producing these subunits and various multimeric combinations of subunits, which are essential for advancing research in neuroscience.
Career Highlights
Allison Gillespie is currently employed at Merck & Company, Inc., where she continues to innovate and contribute to scientific advancements. Her work at Merck has allowed her to collaborate with leading experts in the field and to further her research on neuronal receptors.
Collaborations
Some of her notable coworkers include Brian O Claeps and Laura Elena Chavez-Noriega. Their collaborative efforts have enhanced the research environment and fostered innovation within their projects.
Conclusion
Allison Gillespie's contributions to the field of biotechnology, particularly through her patent on neuronal nicotinic acetylcholine receptors, highlight her role as an influential inventor. Her work continues to pave the way for advancements in neuroscience and therapeutic development.